Share this post on:

Product Name :
KNT-127

Search keywords :
KNT-127

drugId :
null

Target Vo:
δ-opioid receptor

Target Vo Short Name :
DOR1

Moa_Name:
δ-opioid receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kitasato University

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Pain

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Heme Oxygenase 1(HO-1) Rabbit mAb Protocol
Cilgavimab MedChemExpress
ATP Citrate Lyase Antibody (YA829): ATP Citrate Lyase Antibody (YA829) is a non-conjugated and Mouse origined monoclonal antibody about 121 kDa, targeting to ATP Citrate Lyase (3D9). It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Monkey.

Share this post on:

Author: Interleukin Related